H. Christofk, M. Heiden, M. Harris, A. Ramanathan, R. Gerszten, Ru Wei, M. Fleming, S. Schreiber, L. Cantley (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growthNature, 452
V. Mootha, C. Lindgren, K. Eriksson, A. Subramanian, S. Sihag, J. Lehár, P. Puigserver, E. Carlsson, M. Ridderstråle, E. Laurila, N. Houstis, M. Daly, N. Patterson, J. Mesirov, T. Golub, P. Tamayo, B. Spiegelman, E. Lander, J. Hirschhorn, D. Altshuler, L. Groop (2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 34
C. Brandts, B. Sargin, M. Rode, Christoph Biermann, B. Lindtner, J. Schwäble, H. Buerger, C. Müller-Tidow, Chunaram Choudhary, M. McMahon, W. Berdel, H. Serve (2005)
Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation.Cancer research, 65 21
Ji Zhang, N. Pavlova, C. Thompson (2017)
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamineThe EMBO Journal, 36
Ayuna Hattori, M. Tsunoda, T. Konuma, Masayuki Kobayashi, T. Nagy, J. Glushka, Fariba Tayyari, D. McSkimming, N. Kannan, A. Tojo, A. Edison, Takahiro Ito (2017)
Cancer progression by reprogrammed BCAA metabolism in myeloid leukemiaNature, 545
Matt Gross, S. Demo, J. Dennison, Lijing Chen, T. Chernov-Rogan, B. Goyal, J. Janes, Guy Laidig, E. Lewis, Jim Li, A. Mackinnon, F. Parlati, Mirna Rodriguez, P. Shwonek, E. Sjogren, Timothy Stanton, Taotao Wang, Jinfu Yang, F. Zhao, M. Bennett (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast CancerMolecular Cancer Therapeutics, 13
L. Shlush, Sasan Zandi, Amanda Mitchell, W. Chen, J. Brandwein, Vikas Gupta, J. Kennedy, A. Schimmer, A. Schuh, K. Yee, Jessica Mcleod, M. Doedens, Jessie Medeiros, René Marke, Hyeoung-Joon Kim, Kwon Lee, J. McPherson, T. Hudson, Andrew Brown, Quang Trinh, Lincoln Stein, M. Minden, Jean Wang, J. Dick (2014)
Identification of pre-leukemic hematopoietic stem cells in acute leukemiaNature, 506
G. Giotopoulos, G. Giotopoulos, W-I Chan, W-I Chan, W-I Chan, Sarah Horton, Sarah Horton, David Ruau, David Ruau, Paolo Gallipoli, Paolo Gallipoli, A. Fowler, Clayton Crawley, E. Papaemmanuil, Peter Campbell, Peter Campbell, Berthold Göttgens, Berthold Göttgens, J. Deursen, Philip Cole, B. Huntly, B. Huntly (2016)
The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemiaOncogene, 35
P. Ward, Jay Patel, David Wise, O. Abdel-Wahab, Bryson Bennett, H. Coller, J. Cross, V. Fantin, C. Hedvat, A. Perl, J. Rabinowitz, M. Carroll, Shinsan Su, K. Sharp, R. Levine, C. Thompson (2010)
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.Cancer cell, 17 3
Kazuhiro Tanaka, T. Sasayama, Y. Irino, K. Takata, H. Nagashima, Naoko Satoh, K. Kyotani, T. Mizowaki, T. Imahori, Y. Ejima, Kenta Masui, B. Gini, Huijun Yang, K. Hosoda, R. Sasaki, P. Mischel, E. Kohmura (2015)
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.The Journal of clinical investigation, 125 4
Michalis Agathocleous, Corbin Meacham, R. Burgess, E. Piskounova, Zhiyu Zhao, G. Crane, Brianna Cowin, Emily Bruner, M. Murphy, Weina Chen, G. Spangrude, Zeping Hu, R. Deberardinis, S. Morrison (2017)
Ascorbate regulates haematopoietic stem cell function and leukaemogenesisNature, 549
Kıvanç Birsoy, Tim Wang, Walter Chen, Elizaveta Freinkman, M. Abu-Remaileh, D. Sabatini (2015)
An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate SynthesisCell, 162
Amélie Guitart, T. Panagopoulou, Arnaud Villacreces, Milica Vukovic, Catarina Sepulveda, Lewis Allen, R. Carter, L. Lagemaat, Marcos Morgan, P. Giles, Z. Sas, M. González, Hannah Lawson, J. Paris, Joy Edwards-Hicks, K. Schaak, Chithra Subramani, Deniz Gezer, A. Armesilla-Diaz, J. Wills, A. Easterbrook, D. Coman, C. So, D. O’Carroll, D. Vernimmen, N. Rodrigues, Patrick Pollard, N. Morton, A. Finch, Kamil Kranc (2017)
Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functionsThe Journal of Experimental Medicine, 214
M. Figueroa, O. Abdel-Wahab, Chao Lu, P. Ward, Jay Patel, A. Shih, Yushan Li, N. Bhagwat, A. Vasanthakumar, H. Fernandez, M. Tallman, Zhuoxin Sun, K. Wolniak, J. Peeters, Wei Liu, S. Choe, V. Fantin, E. Paietta, B. Löwenberg, J. Licht, L. Godley, R. Delwel, P. Valk, C. Thompson, R. Levine, A. Melnick (2010)
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.Cancer cell, 18 6
P. Zarrinkar, R. Gunawardane, Merryl Cramer, M. Gardner, D. Brigham, B. Belli, Mazen Karaman, K. Pratz, Gabriel Pallares, Q. Chao, K. Sprankle, H. Patel, M. Levis, R. Armstrong, J. James, S. Bhagwat (2009)
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).Blood, 114 14
H. Christofk, M. Heiden, Ning Wu, J. Asara, L. Cantley (2008)
Pyruvate kinase M2 is a phosphotyrosine-binding proteinNature, 452
P. Gao, Irina Tchernyshyov, Tsung-Cheng Chang, Yun‐Sil Lee, Kayoko Kita, T. Ochi, K. Zeller, A. Marzo, J. Eyk, J. Mendell, C. Dang (2009)
c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolismNature, 458
R. Stone, S. Mandrekar, B. Sanford, K. Laumann, S. Geyer, C. Bloomfield, C. Thiede, T. Prior, K. Döhner, G. Marcucci, F. Lo‐Coco, R. Klisovic, A. Wei, J. Sierra, M. Sanz, J. Brandwein, T. Witte, D. Niederwieser, F. Appelbaum, B. Medeiros, M. Tallman, J. Krauter, R. Schlenk, A. Ganser, H. Serve, G. Ehninger, S. Amadori, R. Larson, H. Döhner (2017)
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 MutationThe New England Journal of Medicine, 377
Ying-hua Wang, William Israelsen, Dongjun Lee, V. Yu, N. Jeanson, C. Clish, L. Cantley, M. Heiden, D. Scadden (2014)
Cell-State-Specific Metabolic Dependency in Hematopoiesis and LeukemogenesisCell, 158
A. Subramanian, P. Tamayo, V. Mootha, Sayan Mukherjee, B. Ebert, Michael Gillette, A. Paulovich, S. Pomeroy, T. Golub, E. Lander, J. Mesirov (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 102
M. Gregory, T. Nemkov, J. Reisz, Vadym Zaberezhnyy, K. Hansen, A. D’Alessandro, J. DeGregori (2017)
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.Experimental hematology, 58
R. Verhaak, Bas Wouters, Claudia Erpelinck, Saman Abbas, H. Beverloo, S. Lugthart, B. Löwenberg, R. Delwel, P. Valk (2009)
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profilingHaematologica, 94
S. O’Brien, F. Guilhot, R. Larson, I. Gathmann, M. Baccarani, F. Cervantes, J. Cornelissen, T. Fischer, A. Hochhaus, T. Hughes, K. Lechner, J. Nielsen, P. Rousselot, J. Reiffers, G. Saglio, J. Shepherd, B. Simonsson, A. Gratwohl, J. Goldman, H. Kantarjian, K. Taylor, G. Verhoef, A. Bolton, R. Capdeville, B. Druker (2003)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.The New England journal of medicine, 348 11
Catherine Smith, Qi Wang, C. Chin, S. Salerno, L. Damon, M. Levis, A. Perl, K. Travers, Susana Wang, Jeremy Hunt, P. Zarrinkar, E. Schadt, A. Kasarskis, J. Kuriyan, N. Shah (2012)
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemiaNature, 485
E. Papaemmanuil, Hartmut Döhner, Peter Campbell (2016)
Genomic Classification in Acute Myeloid Leukemia.The New England journal of medicine, 375 9
T. Ley, C. Miller, L. Ding, Benjamin Raphael, A. Mungall, A. Robertson, K. Hoadley, T. Triche, P. Laird, J. Baty, L. Fulton, R. Fulton, S. Heath, Joelle Kalicki-Veizer, C. Kandoth, J. Klco, D. Koboldt, K. Kanchi, S. Kulkarni, T. Lamprecht, D. Larson, Ling Lin, Charles Lu, M. McLellan, Joshua McMichael, J. Payton, Heather Schmidt, D. Spencer, M. Tomasson, J. Wallis, L. Wartman, M. Watson, J. Welch, M. Wendl, Adrian Ally, M. Balasundaram, I. Birol, Y. Butterfield, Readman Chiu, Andy Chu, E. Chuah, Hye-Jung Chun, R. Corbett, Noreen Dhalla, R. Guin, A. He, Carrie Hirst, M. Hirst, R. Holt, Steven Jones, A. Karsan, Darlene Lee, H. Li, M. Marra, Michael Mayo, Richard Moore, K. Mungall, J. Parker, E. Pleasance, Patrick Plettner, J. Schein, D. Stoll, Lucas Swanson, Angela Tam, N. Thiessen, R. Varhol, N. Wye, Yongjun Zhao, S. Gabriel, G. Getz, C. Sougnez, L. Zou, Mark Leiserson, Fabio Vandin, Hsin-Ta Wu, F. Applebaum, S. Baylin, R. Akbani, B. Broom, Ken Chen, Thomas Motter, Khanh Nguyen, J. Weinstein, Nianziang Zhang, M. Ferguson, C. Adams, Aaron Black, Jay Bowen, J. Gastier-Foster, T. Grossman, T. Lichtenberg, L. Wise, Tanja Davidsen, John Demchok, K. Shaw, Margi Sheth, H. Sofia, Liming Yang, J. Downing, G. Eley (2013)
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.The New England journal of medicine, 368 22
K. Tzelepis, Hiroko Koike-Yusa, E. Braekeleer, Yilong Li, E. Metzakopian, O. Dovey, Annalisa Mupo, V. Grinkevich, M. Li, M. Mazan, M. Gozdecka, Shuhei Ohnishi, Jonathan Cooper, M. Patel, Thomas McKerrell, Bin Chen, A. Domingues, P. Gallipoli, S. Teichmann, H. Ponstingl, U. McDermott, J. Saez-Rodriguez, B. Huntly, F. Iorio, C. Pina, G. Vassiliou, K. Yusa (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid LeukemiaCell Reports, 17
Maxim Kuleshov, Matthew Jones, A. Rouillard, Nicolas Fernandez, Qiaonan Duan, Zichen Wang, Simon Koplev, S. Jenkins, Kathleen Jagodnik, Alexander Lachmann, Michael McDermott, Caroline Monteiro, Gregory Gundersen, Avi Ma’ayan (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 updateNucleic Acids Research, 44
David Wise, R. Deberardinis, A. Mancuso, Nabil Sayed, Xiao-yong Zhang, H. Pfeiffer, I. Nissim, E. Daikhin, M. Yudkoff, S. McMahon, C. Thompson (2008)
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addictionProceedings of the National Academy of Sciences, 105
O. Piloto, Melissa Wright, P. Brown, Kyu‐Tae Kim, M. Levis, D. Small (2006)
Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways.Blood, 109 4
O. Griffith (1982)
Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.The Journal of biological chemistry, 257 22
Lucas Sullivan, D. Gui, Aaron Hosios, Lauren Bush, Elizaveta Freinkman, M. Heiden (2015)
Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating CellsCell, 162
E. Chen, Christopher Tan, Y. Kou, Qiaonan Duan, Zichen Wang, G. Meirelles, N. Clark, Avi Ma’ayan (2013)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis toolBMC Bioinformatics, 14
S. Whitman, K. Maharry, M. Radmacher, H. Becker, K. Mrózek, D. Margeson, Kelsi Holland, Yue-zhong Wu, S. Schwind, K. Metzeler, J. Wen, M. Baer, B. Powell, T. Carter, J. Kolitz, M. Wetzler, J. Moore, R. Stone, A. Carroll, R. Larson, M. Caligiuri, G. Marcucci, C. Bloomfield (2010)
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Blood, 116 18
H. Kiyoi, T. Naoe, Y. Nakano, S. Yokota, S. Minami, S. Miyawaki, N. Asou, K. Kuriyama, I. Jinnai, C. Shimazaki, H. Akiyama, Kenji Saito, H. Oh, T. Motoji, E. Omoto, H. Saito, R. Ohno, R. Ueda (1999)
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.Blood, 93 9
Elodie Kuntz, Pablo Baquero, A. Michie, Karen Dunn, S. Tardito, T. Holyoake, G. Helgason, E. Gottlieb (2017)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemic stem cellsNature medicine, 23
Louise Kelly, Qing Liu, J. Kutok, I. Williams, Christina Boulton, D. Gilliland (2002)
FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.Blood, 99 1
Tseng Kf, G. Mukherjee, D. Small (2000)
Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformationLeukemia, 14
Catherine Smith, A. Paguirigan, Grace Jeschke, Kimberly Lin, E. Massi, Theodore Tarver, C. Chin, S. Asthana, A. Olshen, K. Travers, Susana Wang, M. Levis, A. Perl, J. Radich, N. Shah (2017)
Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis.Blood, 130 1
Huai-qiang Ju, G. Zhan, A. Huang, Y. Sun, S. Wen, J. Yang, Wen-hua Lu, R. Xu, J. Li, Y. Li, G. Garcia-Manero, P. Huang, Y. Hu (2017)
ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibitionLeukemia, 31
R. Ren (2005)
Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemiaNature Reviews Cancer, 5
B. Zdzisińska, Aleksandra Żurek, M. Kandefer-Szerszeń (2016)
Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic UseArchivum Immunologiae et Therapiae Experimentalis, 65
Il-kyoo Park, B. Mundy-Bosse, S. Whitman, Xiaoli Zhang, S. Warner, D. Bearss, W. Blum, G. Marcucci, M. Caligiuri (2015)
Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemiaLeukemia, 29
R. Deberardinis, A. Mancuso, E. Daikhin, I. Nissim, M. Yudkoff, S. Wehrli, C. Thompson (2007)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesisProceedings of the National Academy of Sciences, 104
Francesca Alvarez-Calderon, M. Gregory, Catherine Pham-Danis, D. DeRyckere, Brett Stevens, Vadym Zaberezhnyy, A. Hill, Lelisa Gemta, Amit Kumar, Vijay Kumar, M. Wempe, D. Pollyea, C. Jordan, N. Serkova, D. Graham, J. DeGregori (2014)
Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial PerturbationsClinical Cancer Research, 21
Hee-Bum Kang, Jun Fan, Ruiting Lin, Shannon Elf, Q. Ji, Liang Zhao, Lingtao Jin, J. Seo, Changliang Shan, J. Arbiser, C. Cohen, D. Brat, H. Miziorko, Eunhee Kim, O. Abdel-Wahab, T. Merghoub, S. Fröhling, C. Scholl, P. Tamayo, D. Barbie, Lu Zhou, B. Pollack, Kevin Fisher, R. Kudchadkar, D. Lawson, G. Sica, M. Rossi, S. Lonial, H. Khoury, F. Khuri, Benjamin Lee, T. Boggon, Chuan He, Sumin Kang, J. Chen (2015)
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.Molecular cell, 59 3
Lingtao Jin, D. Li, Gina Alesi, Jun Fan, Hee-Bum Kang, Zhouzhou Lu, T. Boggon, P. Jin, H. Yi, Elizabeth Wright, D. Duong, N. Seyfried, Robert Egnatchik, R. Deberardinis, K. Magliocca, Chuan He, M. Arellano, H. Khoury, D. Shin, F. Khuri, Sumin Kang (2015)
Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.Cancer cell, 27 2
Thomas Farge, E. Saland, F. Toni, Nesrine Aroua, M. Hosseini, Robin Perry, C. Bosc, M. Sugita, Lucille Stuani, M. Fraisse, S. Scotland, C. Larrue, Helena Boutzen, Virginie Feliu, Marie-Laure Nicolau-Travers, Stéphanie Cassant-Sourdy, Nicolas Broin, M. David, Nizar Serhan, A. Sarry, S. Tavitian, T. Kaoma, L. Vallar, J. Iacovoni, L. Linares, C. Montersino, R. Castellano, E. Griessinger, Y. Collette, O. Duchamp, Y. Barreira, P. Hirsch, T. Palama, L. Gales, F. Delhommeau, B. Garmy-Susini, J. Portais, F. Vergez, M. Selak, G. Danet-Desnoyers, M. Carroll, C. Récher, J. Sarry (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.Cancer discovery, 7 7
R. Elstrom, D. Bauer, M. Buzzai, Robyn Karnauskas, M. Harris, D. Plas, H. Zhuang, Ryan Cinalli, A. Alavi, C. Rudin, C. Thompson (2004)
Akt Stimulates Aerobic Glycolysis in Cancer CellsCancer Research, 64
Emma Kerr, E. Gaude, Frances Turrell, C. Frezza, C. Martins (2016)
Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilitiesNature, 531
Yuki Taya, Y. Ota, A. Wilkinson, A. Kanazawa, H. Watarai, M. Kasai, H. Nakauchi, S. Yamazaki (2016)
Depleting dietary valine permits nonmyeloablative mouse hematopoietic stem cell transplantationScience, 354
M. Levis (2013)
FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?Hematology. American Society of Hematology. Education Program, 2013
DN Gross, Apj Heuvel, MJ Birnbaum (2008)
The role of FoxO in the regulation of metabolismOncogene, 27
S. Wander, M. Levis, A. Fathi (2014)
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyondTherapeutic Advances in Hematology, 5
M. Mizuki, R. Fenski, H. Halfter, I. Matsumura, R. Schmidt, C. Müller, W. Grüning, K. Kratz-Albers, S. Serve, C. Steur, T. Büchner, J. Kienast, Y. Kanakura, Wolfgang Berdel, H. Serve (2000)
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.Blood, 96 12
N. Jacque, A. Ronchetti, C. Larrue, G. Meunier, R. Birsen, L. Willems, E. Saland, J. Decroocq, T. Maciel, M. Lambert, Laury Poulain, Marie-Anne Hospital, P. Sujobert, Laure Joseph, N. Chapuis, C. Lacombe, I. Moura, S. Demo, J. Sarry, C. Récher, P. Mayeux, J. Tamburini, D. Bouscary (2015)
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.Blood, 126 11
Ling Li, Tereza Osdal, Yinwei Ho, Sookhee Chun, Tinisha McDonald, Puneet Agarwal, A. Lin, S. Chu, Jing Qi, Liang Li, Y. Hsieh, Cedric Santos, Hongfeng Yuan, T. Ha, M. Popa, R. Hovland, Ø. Bruserud, B. Gjertsen, Ya-Huei Kuo, WenYong Chen, S. Laín, E. McCormack, R. Bhatia (2014)
SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells.Cell stem cell, 15 4
Shuli Zhang, S. Fukuda, Younghee Lee, G. Hangoc, S. Cooper, Rosanne Spolski, W. Leonard, H. Broxmeyer (2000)
Essential Role of Signal Transducer and Activator of Transcription (Stat)5a but Not Stat5b for Flt3-Dependent SignalingThe Journal of Experimental Medicine, 192
M. Gregory, A. D’Alessandro, Francesca Alvarez-Calderon, Jihye Kim, T. Nemkov, Biniam Adane, A. Rozhok, Amit Kumar, Vijay Kumar, D. Pollyea, M. Wempe, C. Jordan, N. Serkova, A. Tan, K. Hansen, J. DeGregori (2016)
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemiaProceedings of the National Academy of Sciences, 113
D. Herranz, A. Ambesi-Impiombato, J. Sudderth, M. Sanchez-Martin, Laura Belver, V. Tosello, Luyao Xu, Agnieszka Wendorff, M. Castillo, J. Haydu, J. Márquez, J. Matés, Andrew Kung, S. Rayport, C. Cordon-Cardo, R. Deberardinis, A. Ferrando (2015)
Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemiaNature medicine, 21
D. Hanahan, R. Weinberg (2011)
Hallmarks of Cancer: The Next GenerationCell, 144
Blood – Unpaywall
Published: Apr 12, 2018
Access the full text.
Sign up today, get DeepDyve free for 14 days.